Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism LptD inhibitors(lipopolysaccharide transport protein C inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC41H49ClN10O3S |
InChIKeyBDHOZQIIBFIAMB-IMKBVMFZSA-N |
CAS Registry2097285-98-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acinetobacter Baumannii Infection | Preclinical | DE | 03 Jan 2024 |